Thursday, March 26, 2020

1136 Order from Beijing (Feb 13): Strengthen laboratory management, put an end to the theft, leakage, and loss of pathogenic bacteria

Order from Beijing (Feb 13): Strengthen laboratory management, put an
end to the theft, leakage, and loss of pathogenic bacteria

Newsletter published on March 17, 2020


(1) Order from Beijing (Feb 13): Strengthen laboratory management, put
an end to the theft, leakage, and loss of pathogenic bacteria
(2) Francis Boyle update Update on Coronavirus, March 8, 2020
(3) If virus is a US attack, why have Russia, Venezuela, and Cuba been
spared?
(4) Coronavirus Exposed, by Sir Adrian Bond

(1) Order from Beijing (Feb 13): Strengthen laboratory management, put
an end to the theft, leakage, and loss of pathogenic bacteria

China Vows To Put An End To "Lab Leakage Of Pathogenic Microorganisms
And Various Samples"

by Tyler Durden

Thu, 02/13/2020 - 19:05


Seemingly providing more anecdotal evidence that the Covid-19 outbreak
was caused by an accidental leak of a bio-engineered virus and not by
some freak of nature in Wuhan's market, China's Communist Party has
issued a serious "Wartime Order" demanding more care and containment be
taken with virus handling.


Beijing CDC Party Committee Issues Wartime Status Order

2020-02-13 18:38:07

Wartime Status Order

Party Committee of Beijing Centers for Disease Control

In order to further discipline, compact responsibility, and ensure that
all prevention and control work is carried out in an efficient and
standardized manner, the Party Committee of the Beijing Centers for
Disease Control and Prevention issued a wartime state order, requiring
its party members and employees to fully recognize the "critical
period", "critical moment", and "key points". The urgency and importance
of the moment, consciously established a "very conscious" and entered a
"wartime state."

The first is to insist on using "state of war" to lead the thinking. [...]

The second is to insist on strengthening implementation with "wartime
standards." [...]

The third is to strictly control contact with "wartime thinking." [...]

The fourth is to insist on strict management with "wartime thinking."

Highlight political security, ideological security, network information
security, security of confidential work, laboratory biological security,
food security, etc. The epidemic data collection, statistics and
reporting will be done well, and information security and
confidentiality security incidents will be resolutely prevented.
Front-line personnel engaged in flow regulation, pathogen inspection,
and close management should strictly implement prevention and control
guidelines and operating specifications, do a good job of personal
protection requirements, and ensure personal safety. Strengthen
laboratory management and resolutely put an end to the theft, leakage,
and loss of pathogenic bacteria (poisons) and various samples.

Fifth, we must adhere to the "wartime need" service guarantee. [...]

Sixth, we must adhere to "war discipline" and take it seriously. [...]

(2) Francis Boyle update Update on Coronavirus, March 8, 2020

Francis Boyle update Update on Coronavirus, March 8, 2020 (video):


(3) If virus is a US attack, why have Russia, Venezuela, and Cuba been
spared?

OLDMICROBIOLOGIST writes, "I have zero proof other than my gut feeling
that this is a bioweapon. [...] However, evidence against it being a
bioweapon is Russia, Venezuela, and Cuba are minimally affected. This
could mean effective countermeasures or botched attacks. It is
inconsistent though with the way the CIA operates."


condensed version:
==

(4) Coronavirus Exposed, by Sir Adrian Bond

This is an excellent summary; it's worth saving the webpage:

Coronavirus Exposed, Part 1: Communist Coverup, or Pandemic Bioweapon of
Mass Destruction?

by Adrian Bond


{photo} Coronavirus 2019-nCoV, able to enter and infect human cellsÕ
ACE2 receptor via its spike protein.

The official story about Coronavirus 2019 nCoV is that it "appears to
have originated in the Huanan Seafood Wholesale Market in Wuhan, a
Chinese city about 650 miles south of Beijing that has a population of
more than 11 million people." ...

Typically not included in most mainstream news stories, however, is the
fact that the claimed epicenter of the outbreak is just 8.6 miles from
Wuhan Institute of Virology, which houses ChinaÕs only P4-Level
Biosafety Laboratory capable of storing, studying, or engineering
Pathogen Level 4 microbes such as other coronaviruses, Ebola, Severe
Acute Respiratory Syndrome, SARS, H5N1 influenza virus, Japanese
encephalitis, and dengue. ...

In 2006, one of China's preeminent virologists, Professor Zhengli Shi,
co-authored the study, Review of Bats and SARS, concluding that "a SARS
epidemic may recur in the future and that SARS-like coronaviruses
(SL-CoVs) that originate from different reservoir host populations may
lead to epidemics at different times or in different regions .... The
recent discovery of a group of diverse SL-CoVs in bats support the
possibility of these events  ...." [...]

However, Prof. Zhengli and her co-authors published a study early last
year on March 2, 2019 entitled Bat Coronaviruses in China which
explicitly warned,

"During the past two decades, three zoonotic coronaviruses have been
identified as the cause of large-scale disease outbreaks - Severe Acute
Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS),
and Swine Acute Diarrhea Syndrome (SADS). SARS and MERS emerged in 2003
and 2012, respectively, and caused a worldwide pandemic that claimed
thousands of human lives, while SADS struck the swine industry in 2017.
They have common characteristics, such as they are all highly pathogenic
to humans or livestock, their agents originated from bats, and two of
them originated in China. Thus, it is highly likely that future SARS- or
MERS-like coronavirus outbreaks will originate from bats, and there is
an increased probability that this will occur in China. Therefore, the
investigation of bat coronaviruses becomes an urgent issue for the
detection of early warning signs, which in turn minimizes the impact of
such future outbreaks in China" (emphasis added). [...]

Apparently, the virology scientific community not only failed to heed
Prof. ZhengliÕs explicit, recent dire warnings about the "high
likelihood" that future SARS- or MERS-like coronavirus outbreaks would
originate from bats - they also ignored ZhengliÕs incredibly pertinent
report published ten years ago in July, 2010, Identification of key
amino acid residues required for horseshoe bat angiotensin-I converting
enzyme 2 to function as a receptor for severe acute respiratory syndrome
coronavirus. The studyÕs abstract canÕt be clearer on the immunological
risks associated with protein ACE2, with its obvious liability for
usurpation by viral agents with a little modified genome sequencing:

"Angiotensin-I converting enzyme 2 (ACE2) is the receptor for severe
acute respiratory syndrome (SARS) coronavirus (SARS-CoV). A previous
study indicated that ACE2 from a horseshoe bat, the host of a highly
related SARS-like coronavirus, could not function as a receptor for
SARS-CoV. Here, we demonstrate that a 3 aa change from SHE (aa 40–42) to
FYQ was sufficient to convert the bat ACE2 into a fully functional
receptor for SARS-CoV. We further demonstrate that an ACE2 molecule from
a fruit bat, which contains the FYQ motif, was able to support SARS-CoV
infection, indicating a potentially much wider host range for
SARS-CoV-related viruses among different bat populations."

This old but remarkable study concludes that only a minor genome
sequence change was required to convert a non-susceptible bat ACE2
protein into a functional receptor for SARS-CoV, something that could
easily happen in nature. "Considering that there are more than 60
different horseshoe [bat] species around the world (Flanders et al.,
2009; Rossiter et al., 2007), it is possible that one or some of them
may serve as the natural reservoir of SARS-CoV and/or its progenitor
virus(es)."

Why is it that current State virologists are apparently ignorant of
these essential discoveries of yesteryear? [...]

And the new study on Coronavirus 2019-nCoV by the joint research team
from the Chinese Academy of Sciences, the People's Liberation Army, and
Institut Pasteur of Shanghai indeed found that, like SARS, the virus
targeted the ACE2 protein. It's just as Prof. Zhengli predicated a
decade ago: " ...the fact that an ACE2 protein from a megabat, the fruit
bat Rousettus leschenaultia, can function as a receptor for SARS-CoV
would suggest that the host range for SARS-CoV or SL-CoVs may be much
wider than originally thought."

So what happened - did the virology and surrounding scientific community
drop the ball on these well-established findings and warnings, or what?
After all, at least as February, 2008, they knew three key facts about ACE2:

Severe acute respiratory syndrome (SARS) is caused by the
SARS-associated coronavirus (SARS-CoV), which uses ACE2 as its receptor
for cell entry. SL-CoVs and SARS-CoVs share identical genome
organizations and high sequence identities, with the main exception of
the N terminus of the spike protein, known to be responsible for
receptor binding in CoVs.

Whereas the SL-CoV spike protein was unable to use any of the three ACE2
molecules as its receptor, and the SARS-CoV spike protein failed to
center cells expressing the bat ACE2, the chimeric spike protein the
study created did gain its ability to center cells via human ACE, and A
minimal insert region (amino acids 310 to 518) was found to be
sufficient to convert the SL-CoV S from non-ACE2 binding to human ACE2
binding, indicating that the SL-CoV S is largely compatible with
SARS-CoV S protein both in structure and in function.

We know they knew these facts way back in 2008 because Prof. Zhengli
published the findings of these facts in her report, Difference in
Receptor Usage between Severe Acute Respiratory Syndrome (SARS)
Coronavirus and SARS-Like Coronavirus of Bat Origin. Therein the
scientists concluded, "Knowing the capability of different CoVs to
recombine both in the laboratory and in nature, the possibility that
SL-CoVs may gain the ability to infect human cells by acquiring spike
protein sequences competent for binding to ACE2 or other surface
proteins of human cells can be readily envisaged."

Thus, it seems strange and perhaps even disingenuous that the new joint
CCP government-joint Coronavirus 2019-nCoV task force is seemingly
ignorant about coronavirus targeting the ACE2 protein, apparently
pretending it's only just now discovered this. After all, Zhengli's 2008
report was quite clear about the role that this ACE2 protein would play
in future pandemics: the study "strengthened our belief that ACE2 from
certain bat species could be able to support SARS-CoV infection because
of the predicted genetic diversity of bat ACE2 variants in different bat
species." [...]

At any rate, the forgoing storyline is the official word on Coronavirus
2019-nCoV, manifesting itself somehow in a seafood market in Wuhan. [...]

China's National Biosafety Laboratory, located at Wuhan Institute of
Virology, is only 8.6 miles away from the claimed epicenter of the
Coronavirus 2019-nCoV outbreak. Do you believe in coincidences? What's
odd is that despite completing the decade-long construction and having
the official inauguration of this P4 laboratory on January 31, 2015 -
announced by the General Office of Hubei Provincial People's Government,
it wasn't until 2 and 1/2 years later in January 2018, that the Chinese
government announced that the lab was actually in operation. And ahead
of the lab's second opening in January 2018, biosafety experts and
scientists from the United States expressly warned "that a SARS-like
virus could escape," much in the same way the SARS virus had escaped
multiple times from a lab in Beijing. [...]

Wuhan Institute of Virology is also connected with the recent, major
scandal in Canada where two Chinese virologists working at Canada's only
Pathogen Level 4 virology laboratory, the National Microbiology Lab
(NML) in Winnipeg were caught stealing and smuggling some of the most
deadly viruses on earth, including the Ebola virus, back to China. The
suspects - a Chinese couple, virologist Dr. Xiangguo Qui and biologist
Dr. Keding Cheng - are now believed to be connected to China's
biological warfare program. Her husband, Dr. Qiu, was head of the
Vaccine Development and Antiviral Therapies Section in the Special
Pathogens Program at the NML. Dr. Keding Cheng, also affiliated with the
NML, specifically the "Science and Technology Core," is primarily a
bacteriologist who shifted to virology. According to ZeroHedge, "the
couple is responsible for infiltrating Canada's NML with many Chinese
agents as students from a range of Chinese scientific facilities
directly tied to China's Biological Warfare Program, including the Wuhan
Institute of Virology and the Center for Disease Control and Prevention
in Chengdu Military Region.

And guess what one of the stolen viruses was? Yup, coronavirus. On May
4, 2013, NML's Scientific Director Frank Plummer received a shipment of
coronavirus from a Dutch virologist, who in turn had received it from an
Egyptian virologist treating a Saudi Arabian who contracted it. The
Canadian lab grew stocks of the virus, and then experimented upon
animals to see what they could infect with it. It is from this stash of
reserves that the coronavirus was stolen and smuggled by Dr. Qui, Dr.
Cheng, and by alledged Chinese Biological Warfare Program agents
recruited from the Wuhan Institute of Virology who were disguised as
virology students at the University of Manitoba. Similarly, and perhaps
connected, is the recent indictment of Charles Lieber, Chair of Harvard
University's Department of Chemistry and Chemical Biology. Prosecutors
claim he had a contract with Wuhan Institute of Virology. Reports CBS,
"It appears China paid Lieber hundreds of thousands of dollars over the
years for his involvement with the Chinese entities and for his work on
research for Chinese gain," said U.S. Attorney for Massachusetts Andrew
Lelling."

Lieber lied about his links to Wuhan Institute of Virology, report Tonya
Alanez and Travis Andersen of the Boston Globe. "Federal authorities
said Charles Lieber, a prominent nanoscientist and a prolific inventor
and entrepreneur, received hundreds of thousands of dollars from his
Chinese connections."

Details about the extent of Lieber's illicit and illegal conspiracy with
the institute have yet to emerge. So this means, significantly, that not
only are there Chinese nationals allegedly being recruited from Wuhan
Institute of Virology to penetrate foreign P4 biosafety laboratories
abroad and smuggle the spoils back home, but it also appears Americans
and Canadians may be complicit in aiding the Chinese biowarfare program.
[...]

In fact, Prof. Zhengli has been Senior Scientist and Principal
Investigator of Wuhan Insititute of Virology for the last 20 years,
initially starting as a Research Assistant in 1990 before upgrading to
Research Scientist in 1993, serving in that role until 1995. Aside from
a 5-year leave from 1995 to 2000 to get her PhD at University of
Montpellier in France, she's been at the Institute for an amazing 30 years.

Notably, starting in 2014, Prof. Zhengli began to win particularly large
sums of grant funding for the express purpose of researching and
experimenting with coronaviruses - often receiving numerous, overlapping
grants for the same time period. What's just as interesting is where a
lot of this funding originated - the US government. On January 6, 2014,
Prof. Zhengli received a US$665,000 grant from the National Institute of
Health for a study named The Ecology of Bat Coronaviruses and the Risk
of Future Coronavirus Emergence (NIAID R01 AI1 10964) and then four days
later on January 10, 2014, an additional US$559,500 grant from the
United States Agency of International Development for research studied
entitled Emerging Pandemic Threats PREDICT 2_China (Project No.
AID-OAA-A-14–00102).

On top of these lucrative American grants she concurrently received
similarly significant grants from the National Basic Research program of
China, the Chinese Academy of Science, the National Natural Science
Foundation of China, and from the Strategic Priority Research Program of
Chinese Academy of Sciences totaling over US$2,500,000 for researching
interspecies transmission of zoonotic viruses, the identification,
genetic evolution and pathogenesis of bat viruses, the genetic variation
of pathogens in Africa, the evolution mechanism of the adaptation of bat
SARS-related coronaviruses to host receptor molecules, the risk of
interspecies infection, genetic evolution and transmission mechanism of
important bat-borne viruses, and pathogen biology studies on novel swine
coronaviruses.

In just the past five years alone, Prof. Zhengli Shi has almost US$10
million in grants to study coronaviruses. [...]

Prof. Zhengli appears to be one of the world's leading bat virologists -
and most definitely the leading bat virologist in China. Indeed, her
C.V. explicitly states,

"Prof. Zhengli Shi 's researches focus on the molecular epidemiology and
interspecies infection discovery and characterization of novel viruses
in bats and other wildlife. She has gain [sic] rich expertise on
pathogen biology of coronaviruses and other emerging viruses of bat
origin, virus discovery, virus evolution, and development of diagnostic
technologies for emerging viruses. Prof Shi has identified ultimately
the animal origin of SARS, by discovering genetically diverse bat SARS
related coronaviruses (SARSr CoV), isolating bat SARSr CoVs highly
homologous to SARS CoV that are able to the same receptor [sic] as SARS
CoV, and revealing the potential recombination origin of SARS CoV. She
has discovered a large number of novel viruses from Chinese bat
populations, including viruses with potential public health significance."

Unsurprisingly, Prof. Zhengli has been featured as a key presenter at
over two dozen international virology conferences, the latest being SARS
to SADS: predict of emerging infectious diseases, held at UC Berkeley in
the summer of 2018. Her presentations at the next five most recent
conferences all relate specifically to the genetic evolution and
interspecies infection of bat coronaviruses. A complete list of Prof.
ZhengliÕs conference presentations may be found in Appendix B.

Nearly all of Prof. Zhengli's recent conference presentations relate to
bat coronaviruses. Do you believe in coincidences?

Prof. Zhengli has been or is currently a professional member of the
Chinese Society for Biochemistry and Molecular Biology (2000–2016), the
Chinese Society for Microbiology (2002-present), the American Society
for Microbiology (2007-present), and the Scientific Committee of the
DIVERSITAS ecoHEALTH Core Project (2014–2016). She has served on the
Editorial Board of Virologica Sinica (2016–2016), on the Editorial Board
of Journal of Medical Virology (2015–2017), and on the Editorial Board
of Virology (2017–2019). She was Associate Editor of Virology Journal
(2016–2018), and Editor-in-Chief of Virologica Sinica (2017–2019). Prof.
Zhengli is also the recipient of numerous, prestigious awards and
honors, including the Natural Science Award of Hubei Province, China
(First Prize and Second Prize), Outstanding Scientist of the Chinese
Academy of Sciences, and Outstanding Research Article on Natural Science
(Grand Prize and Second Prize). OK, but how is Prof. Zhengli relevant to
the current new outbreak of Coronavirus 2019-nCoV?

Chinese scientists, researchers, and doctors examining the emergent
2019-nCoV Coronavirus report that the new viral menace appears to be "a
recombinant virus between the bat coronavirus and an origin-unknown
coronavirus. The recombination occurred within the viral spike
glycoprotein, which recognizes cell surface receptor."

But Prof. Zhengli appears to have worked with recombinant Coronavirus
derivations involving viral spike proteins for over a decade at Wuhan
Institute of Virology, all the way back to 2006 and up to as recently as
December, 2019 - the very month that 2019-nCoV Coronavirus was first
reported as having infected visitors at Huanan Seafood Wholesale Market
just down the road from her laboratory! [...]

In a letter to the editor of SCIENCE CHINA Life Sciences published in
November, 2017, entitled Cross-neutralization of SARS
coronavirus-specific antibodies against bat SARS-like coronaviruses,
Prof. Zhengli warns that severe acute respiratory syndrome coronavirus
(SARS-CoV) is considered to be an emerging zoonotic pathogen crossing
species barriers to infect humans, and that the spike protein of the
virus' RNA genome plays a key role in human cellular entry. In that same
month, the results of a study Prof. Zhengli conducted, Serological
evidence of bat SARS-related coronavirus infection in humans, China
indicated that some SARSr-CoVs may have high potential to infect human
cells, without the necessity for an intermediate host. In 2016, one of
the Directors at Wuhan Institute of Virology posted the annual
Director's Message, of which the following finding was the top
announcement: "The live SARS-like coronavirus SL-CoV-WIV1 has been
isolated for the first time from the bat droppings; and such virus has
been confirmed to invade the host cells through the ACE2 of human
beings, civets and Rhinolophus sinicus. The research result has so far
provided the most convincing evidence to the view that Rhinolophus
sinicus is the natural host of SARS-CoV (Nature, 2013)."

Does this not sound precisely like Coronavirus 2019-nCoV, which invades
the host cells through the ACE2 protein? At any rate, since Prof.
Zhengli is Senior Scientist and Principal Investigator of both the
Emerging Viruses Group and the National Biosafety Laboratory, this is
squarely her turf; the current outbreak seems amazingly similar. [...]

Basically, she is tremendously versatile and adept in her research
whenever she encounters these recombinant spikes proteins in viral
interactions. Moreover, it's not just coronaviruses from bats that she
and her team have discovered and explored, but also diverse novel
viruses/virus antibodies in bats, including adenoviruses,
adeno-associated viruses, circoviruses, paramyxoviruses, and
filoviruses. In fact, Prof. Zhengli has coauthored over an astounding
130 publications on viral pathogen identification, diagnosis and
epidemiology - nearly all of which commandeered at Wuhan Institute of
Virology where the National Biosafety Laboratory is located and where
she reigns as Head of the Department. In fact, on the World Society for
Virology website, Prof. Zhengli's profile confirms that one of her great
contributions was to "uncover genetically diverse SARS-like
coronaviruses in bats with her international collaborators and provide
unequivocal evidence that bats are natural reservoirs of SARS-CoV."

Thus, her adeptness in the specialized field of bat virology -
especially where transmission to humans is concerned - is inarguable.

Such an expansive personal history of expertise into coronaviruses is
not only impressive, but unique, and the bulk of her 30-year career at
Wuhan Institute Virology seems to have been dedicated primarily to the
examination and exploration of all facets of interspecies (though
primarily bat) pathogenic infection of coronaviruses into human host
cells. For reference, you can check Appendix A for the sum total of all
her published (or otherwise unclassified or declassified) studies at the
end of this essay. Prof. Zhengli's absolute mastery of bat-to-human
transmission of viruses via their spike protein binding with human cell
receptors is virtually conclusive and unrivalled. [...]

Why did the US National Institute of Health (NIH) grant Prof. Zhengli
$665,000 in 2014 to fund her study, The ecology of bat coronaviruses and
the risk of future coronavirus emergence? What did the US receive in return?

Why did the United States Agency of International Development grant
Prof. Zhengli $559,500 to fund her study, Emerging Pandemic Threats
PREDICT 2_China? What did the US receive in return? Why did Prof.
Zhengli receive funding from U.S. Department of Defense, the U.S.
Defense Threat Reduction Agency (the agency which deals specifically
with Weapons of Mass Destruction), the U.S. Biological Defense Research
Directorate of the Naval Medical Research Center, and the Department of
Atomic of the Government of India? What other professional relationships
with U.S. defense agencies does Prof. Zhengli have currently, or
previously, in any capacity?

When Prof. Zhengli received a visa to the United States to present at
the Cell Symposium: Emerging and Re-emerging Viruses 2017 conference in
Arlington, Virginia, did she visit the Pentagon or meet with Pentagon
officials, since it was less than a mile away?

When Prof. Zhengli received a visa to the United States to present at
the US-China Workshop on Frontiers in Ecology and Evolution of
Infectious Diseases conference at UC Berkeley in 2018, did she visit
Federal research facility, Lawrence-Berkeley-Livermore Laboratory - in
particular, the Department of Energy's Joint Genome Institute - or meet
with government officials, since it was only a mile and a half away?

Prof. Zhengli's C.V. indicates she received a visa to the United States
to present at the U.S.-China Dialogue on the Challenges of Emerging
Infections, Laboratory Safety and Global Health Security conference on
January 17, 2018, in Galveston, Texas. However, such a conference
appears to not have existed. For what purpose did she really come to
Galveston - perhaps to visit the Galveston National Laboratory, a high
security National Biocontainment Laboratory housing several Biosafety
Level 4 research laboratories, one of the only 15 biosecurity Level 4
facilities in the United States and the largest one in the world located
on an academic campus? Was this apparently imaginary conference merely a
ruse for a surreptitious rendezvous? [...]

Considering Prof. Zhengli is the recipient of millions of dollars in
grants and salaries, commands one of the world's leading, most advanced
biosafety laboratories, has performed innumerable research studies into
coronaviruses for three decades and counting — what vaccines, to date,
has she successfully produced? Has she produced any successful
coronavirus vaccines at all? If so, where are they and how have they
been publicly administered? [...]

At the time of the new coronavirus outbreak, or immediately preceding
it, Prof. Zhengli was actively conducting coronavirus experiments and
research at the Wuhan National Biosafety Laboratory. Notably, the very
next day following the publishing of her coronavirus study on December
11, 2019, the first victims of Coronavirus 2019-nCoV were reported, as
confessed by Prof. Zhengli herself in her most recent, latest report,
posted online on January 23, 2020: "The epidemic, started from December
12th, 2019, has caused 198 laboratory confirmed infections with three
fatal cases by January 20th, 2020."

Most alarming is the apparent, glaring disingenuousness of Prof.
Zhengli's latest report, which is the only public statement since the
official Chinese acknowledgement of Coronavirus 2019-nCoV outbreak in
Wuhan. On January 23, 2020, she published the report with the allegedly
misleading statements:

"Finally, based on our results, it should be expected and worth to test
if ACE2 targeting or SARS-CoV targeting drugs can be used for nCoV-2019
patients. At this stage, we know very little about the virus, including
basic biology, animal source or any specific treatment. The almost
identical sequences of this virus in different patients imply a probably
recent introduction in humans, thus future surveillance on viral
mutation and transmission ability and further global research attention
are urgently needed."

However, other Chinese scientists reported on January 22, 2020, "Results
obtained from our analyses suggest that the 2019-nCoV appears to be a
recombinant virus between the bat coronavirus and an origin-unknown
coronavirus. The recombination occurred within the viral spike
glycoprotein, which recognizes cell surface receptor."

Our findings suggest "that homologous recombination within the spike
glycoprotein may contribute to cross-species transmission."

Although this other scientific team incorrectly attributes the
originating species as reptilian (snake) instead of bats, they at least
rapidly identified the coronavirus as a recombinant virus with one of
the contributors being a bat coronavirus, and also discerned in what
manner the genetic recombination occurred to allow for human infection:
in a viral spike protein which recognized the cell surface receptor. But
as shown previously, this precise area of coronavirus study involving
spike protein and cell surface receptor was the focus of Prof. Zhengli's
contemporaneous December 2019 study published the day before the
epidemic started. "Coronavirus spike protein mediates viral entry into
cells by first binding to a receptor on host cell surface and then
fusing viral and host membranes," she wrote. Why would she feign
ignorance about this?

Even more concerning, on October 31, 2019, Prof. Zhengli had published a
report entitled Filovirus-reactive antibodies in humans and bats in
Northeast India imply zoonotic spillover, curiously funded by the U.S.
Department of Defense, the U.S. Defense Threat Reduction Agency, the
U.S. Biological Defense Research Directorate of the Naval Medical
Research Center, and the Department of Atomic Energy of the Government
of India, and edited by a microbiologist employed by the U.S. Center for
Disease Control.

U.S. Defense Threat Reduction Agency? Can viruses from bats be used as
weapons of mass destruction?

Of note is the fact that the Defense Threat Reduction Agency is an
agency within the U.S. Department of Defense and is the official Combat
Support Agency for countering weapons of mass destruction. Why would
they be funding this project? [...]

All of the studies cited here appear related and interconnected, and
considering the involvement of American defense agencies — in
particular, the U.S. Defense Threat Reduction Agency which deals
exclusively with matters pertaining to weapons of mass destruction and
threat networks — there seems ample reason to be gravely concerned. And
that concern remains whether there's reason to suspect coronaviruses
could be used by others as bioweapons of mass destruction, or that
rogue, Deep State operatives within our own defense departments —
colluding with Communists — are developing or have already developed a
bioweapon of mass destruction. In conclusion, though admittedly much
investigation remains to be performed (especially into the numerous
unanswered questions posed in this essay), it seems the likeliest source
of origin for Coronavirus 2019-nCoV is the Wuhan National Biosafety
Laboratory at the Wuhan Institute of Virology. Further, it appears to me
that, at best, there may be concerted efforts to conceal the precise
nature of the virus, its source, and the parties responsible, or that,
at worst, the dissemination of the epidemic coronavirus is intentional.
Could the actual RNA genome source, sequencing and recombination of the
coronavirus already be known, and could its vaccine have already been
developed? Could it already be patented? Essentially, is this latest
global pandemic threat a Communist cover-up, or a pandemic bioweapon of
mass destruction developed by the global Deep State?

FOR APPENDIX A AND APPENDIX B, VISIT THE LINK.

END

Question: the authors at Global Research, and others alleging that
2019-nCoV is a US attack on China, do not mention Shi Zhengli. Why not,
given that she is the world's leading expert on bat coronaviruses, and
that her lab is only a few miles from Wuhan seafood market?

1

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.